Joint Centre of Translational Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health); Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325000, China.
Adv Sci (Weinh). 2024 Apr;11(13):e2306088. doi: 10.1002/advs.202306088. Epub 2024 Jan 19.
The unprecedented demand for variants diagnosis in response to the COVID-19 epidemic has brought the spotlight onto rapid and accurate detection assays for single nucleotide polymorphisms (SNPs) at multiple locations. However, it is still challenging to ensure simplicity, affordability, and compatibility with multiplexing. Here, a novel technique is presented that combines peptide nucleic acid (PNA) clamps and near-infrared (NIR)-driven digital polymerase chain reaction (dPCR) to identify the Omicron and Delta variants. This is achieved by simultaneously identifying highly conserved mutated signatures at codons 19, 614, and 655 of the spike protein gene. By microfluidically introducing graphene-oxide-nanocomposite into the assembled gelatin microcarriers, they achieved a rapid temperature ramping-up rate and switchable gel-to-sol phase transformation synchronized with PCR activation under NIR irradiation. Two sets of duplex PCR reactions, each classifying respective PNA probes, are emulsified in parallel and illuminated together using a homemade vacuum-based droplet generation device and a programmable NIR control module. This allowed for selective amplification of mutant sequences due to single-base-pair mismatch with PNA blockers. Sequence-recognized bioreactions and fluorescent-color scoring enabled quick identification of variants. This technique achieved a detection limit of 5,100 copies and a 5-fold quantitative resolution, which is promising to unfold minor differences and dynamic changes.
为应对 COVID-19 疫情,对变体诊断的空前需求使人们将注意力集中在能够快速、准确地检测多个位置单核苷酸多态性 (SNP) 的方法上。然而,要确保方法简单、经济实惠且与多重检测兼容仍然具有挑战性。在此,我们提出了一种将肽核酸 (PNA) 夹和近红外 (NIR) 驱动的数字聚合酶链反应 (dPCR) 相结合的新技术,用于鉴定奥密克戎和德尔塔变体。该方法通过同时鉴定刺突蛋白基因密码子 19、614 和 655 处高度保守的突变特征来实现这一点。通过将氧化石墨烯纳米复合材料微流控引入组装的明胶微载体中,它们实现了快速的温度上升率和与 NIR 照射下 PCR 激活同步的可切换凝胶-溶胶相转变。两组双 PCR 反应,每个反应分类各自的 PNA 探针,通过自制的基于真空的液滴生成装置和可编程的 NIR 控制模块并行乳化并一起照射。这允许由于与 PNA 阻断物的单碱基对不匹配而选择性扩增突变序列。序列识别的生物反应和荧光颜色评分可快速识别变体。该技术的检测限为 5,100 拷贝,定量分辨率为 5 倍,有望展开细微差异和动态变化的研究。